Direct Program News Today

First drug approved for seborrheic dermatitis with a new mechanism of action in over two decades available in pharmacies this weekEffective, safe, and very well-tolerated steroid-free foam provides...

ZORYVE foam represents a highly effective, safe, well-tolerated, once-daily steroid-free foam for use on all affected areas of the body, including hair-bearing areas, with no limitations on duration...

The new partnership includes a pathway for both airline pilots and maintenance technicians.

Amazon Kindle is reportedly being flooded with AI-generated books, with many appearing on best-seller lists. Due to the ease of self-publishing, anyone can generate AI-written books and sell them on the platform.

The Wisconsin Department of Health Services has submitted its plan to use nearly $8 million in opioid settlement funds to the Legislature’s Joint Committee on Finance to support prevention, harm reduction, and capital projects to address the state’s opioid crisis.

Money is part of the $400 million award the state receives annually from settlements with pharmaceutical companies

Type One Energy announced today the close of an over-subscribed $29 million financing round. This effort launches the company’s ambitious, partner-rich and capital-efficient FusionDirect program to commercialize its stellarator fusion technology.

The U.S. Supreme Court recently declined to review a Second Circuit decision that blocked Pfizer from implementing a cost sharing assistance program.

The U.S. Supreme Court recently declined to review a Second Circuit decision that blocked Pfizer from implementing a cost sharing assistance program. Pfizer had sought to cover...

MADISON (WJFW) - The Wisconsin Department of Health Services is asking the public for ideas on how to use a second round of opioid settlement funds.